JP2010502738A5 - - Google Patents

Download PDF

Info

Publication number
JP2010502738A5
JP2010502738A5 JP2009527584A JP2009527584A JP2010502738A5 JP 2010502738 A5 JP2010502738 A5 JP 2010502738A5 JP 2009527584 A JP2009527584 A JP 2009527584A JP 2009527584 A JP2009527584 A JP 2009527584A JP 2010502738 A5 JP2010502738 A5 JP 2010502738A5
Authority
JP
Japan
Prior art keywords
chor
lower alkyl
independently
sodium channel
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009527584A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010502738A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/077880 external-priority patent/WO2008031028A2/en
Publication of JP2010502738A publication Critical patent/JP2010502738A/ja
Publication of JP2010502738A5 publication Critical patent/JP2010502738A5/ja
Pending legal-status Critical Current

Links

JP2009527584A 2006-09-07 2007-09-07 ナトリウムチャネル遮断剤および浸透圧調節物質での処置により粘膜水和および粘膜クリアランスを増強する方法 Pending JP2010502738A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84266906P 2006-09-07 2006-09-07
US84517106P 2006-09-18 2006-09-18
PCT/US2007/077880 WO2008031028A2 (en) 2006-09-07 2007-09-07 Methods of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes

Publications (2)

Publication Number Publication Date
JP2010502738A JP2010502738A (ja) 2010-01-28
JP2010502738A5 true JP2010502738A5 (enExample) 2010-10-21

Family

ID=39158091

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009527584A Pending JP2010502738A (ja) 2006-09-07 2007-09-07 ナトリウムチャネル遮断剤および浸透圧調節物質での処置により粘膜水和および粘膜クリアランスを増強する方法

Country Status (12)

Country Link
US (1) US8058278B2 (enExample)
EP (1) EP2059237A4 (enExample)
JP (1) JP2010502738A (enExample)
KR (1) KR20090065508A (enExample)
AR (1) AR062741A1 (enExample)
AU (1) AU2007294547A1 (enExample)
BR (1) BRPI0716884A2 (enExample)
CA (1) CA2663041A1 (enExample)
EA (1) EA200970258A1 (enExample)
MX (1) MX2009002602A (enExample)
TW (1) TW200817343A (enExample)
WO (1) WO2008031028A2 (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858615B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
US7638138B2 (en) 2003-02-21 2009-12-29 Translational Research, Ltd. Compositions for nasal administration of pharmaceuticals
MXPA05010379A (es) 2003-03-27 2006-05-31 Bioactis Ltd Aparato para administrar una medicina en polvo en la cavidad intranasal.
PT1663235E (pt) * 2003-08-18 2013-10-29 Parion Sciences Inc Novos bloqueadores dos canais do sódio de pirazinoílguanidina protegida
US8673360B2 (en) * 2004-08-10 2014-03-18 Shin Nippon Biomedical Laboratories, Ltd. Compositions that enable rapid-acting and highly absorptive intranasal administration
US7399766B2 (en) * 2004-08-18 2008-07-15 Parion Sciences, Inc. Soluble amide & ester pyrazinoylguanidine sodium channel blockers
US7807834B2 (en) 2005-08-03 2010-10-05 Parion Sciences, Inc. Capped pyrazinoylguanidine sodium channel blockers
WO2007146867A2 (en) * 2006-06-09 2007-12-21 Parion Sciences Inc. Aliphatic pyrazinoylguanidine sodium channel blockers with beta agonist activity
US8163758B2 (en) * 2006-06-09 2012-04-24 Parion Sciences, Inc. Phenyl substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity
JP2010502739A (ja) * 2006-09-07 2010-01-28 パリオン・サイエンシィズ・インコーポレーテッド ナトリウムチャネル阻害剤及び浸透圧調節物質を用いた処置による粘膜水和及び粘液クリアランスの改善
JP5415769B2 (ja) 2006-12-26 2014-02-12 株式会社新日本科学 経鼻投与用製剤
WO2008124496A1 (en) * 2007-04-03 2008-10-16 Parion Sciences, Inc. Method of treating acid-sensing ion channel mediated pain, cough, and central nervous system disorders
WO2008124491A1 (en) * 2007-04-03 2008-10-16 Parion Sciences, Inc. Pyrazinoylguanidine compounds for use taste modulators
DE102007040615A1 (de) * 2007-08-27 2009-03-05 Bitop Ag Osmolyte zur Behandlung von allergisch oder viral bedingten Atemwegserkrankungen
EP2211956A4 (en) 2007-10-10 2014-07-09 Parion Sciences Inc DISPOSAL OF OSMOLYTES WITH A NOSE CANNULA
DE102007052380A1 (de) * 2007-10-31 2009-05-07 Bitop Ag Osmolythaltige Zubereitungen zur Anwendung bei trockenen Schleimhäuten
KR101654549B1 (ko) * 2008-02-26 2016-09-07 패리온 사이언스 인코퍼레이티드 다중방향족 나트륨 채널 차단제
US9486418B2 (en) * 2008-04-08 2016-11-08 Dynamis Pharmaceuticals, Inc. Method for treating or preventing dry eye disorders using alkylamino-polyhydroxyalkanes
US20100074881A1 (en) * 2008-07-11 2010-03-25 Parion Sciences, Inc. Multiple nebulizer systems
US9101539B2 (en) * 2009-05-15 2015-08-11 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
GB2472327B (en) 2009-07-31 2013-03-13 Shin Nippon Biomedical Lab Ltd Intranasal granisetron and nasal applicator
US8945605B2 (en) 2011-06-07 2015-02-03 Parion Sciences, Inc. Aerosol delivery systems, compositions and methods
US8778383B2 (en) 2011-06-07 2014-07-15 Parion Sciences, Inc. Methods of treatment
BR112013032771B1 (pt) 2011-06-27 2021-01-12 Parion Sciences, Inc. dipeptídio quimicamente e metabolicamente estável possuindo potente atividade bloqueadora de canais de sódio
AR086745A1 (es) * 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
DK2855435T3 (en) * 2012-05-29 2018-07-16 Parion Sciences Inc DENDRIMER-LIKE AMINOAMIDES WITH SODIUM CHANNEL BLOCKING ACTIVITY FOR THE TREATMENT OF DRY EYES AND OTHER MILK DISEASES
WO2014036445A2 (en) * 2012-08-31 2014-03-06 Johnson Michael R Novel mucolytic agents
CA2894279A1 (en) * 2012-12-07 2014-06-12 Paul Boucher Nasal cannula for delivery of aerosolized medicaments
BR112015014349A2 (pt) 2012-12-17 2017-07-11 Parion Sciences Inc derivados de cloro-pirazina carboxamida úteis para o tratamento de doenças favorecidas por hidratação mucosa insuficiente
ES2674665T3 (es) * 2012-12-17 2018-07-03 Parion Sciences, Inc. Compuestos de 3,5-diamino-6-cloro-N-(N-(4-fenilbutilo)carbamimidoilo)-pirazina-2-carboxamida
US9029382B2 (en) 2012-12-17 2015-05-12 Parion Sciences, Inc. 3,5-diamino-6-chloro-N-(N-(4-phenylbutyl)carbamimidoyl) pyrazine-2-carboxamide compounds
AU2014309251B2 (en) 2013-08-23 2018-05-24 Parion Sciences, Inc. Dithiol mucolytic agents
US9102633B2 (en) 2013-12-13 2015-08-11 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
US20150376145A1 (en) 2014-06-30 2015-12-31 Parion Sciences, Inc. Stable sodium channel blockers
CN112321472A (zh) * 2015-01-30 2021-02-05 帕里昂科学公司 新型单硫醇粘液溶解剂
CN107708680A (zh) 2015-04-30 2018-02-16 帕里昂科学公司 新的二硫醇粘液溶解剂的前药
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4501729A (en) * 1982-12-13 1985-02-26 Research Corporation Aerosolized amiloride treatment of retained pulmonary secretions
KR930701992A (ko) * 1990-10-05 1993-09-08 웨인 알.조운즈 환자의 폐에 잔존하는 점액 분비물의 제거 방법
AUPM411494A0 (en) * 1994-02-25 1994-03-24 Central Sydney Area Health Service Method and device for the provocation of upper or lower airway narrowing and/or the induction of sputum
US5656256A (en) * 1994-12-14 1997-08-12 The University Of North Carolina At Chapel Hill Methods of treating lung disease by an aerosol containing benzamil or phenamil
US6264975B1 (en) * 1998-10-20 2001-07-24 The University Of North Carolina At Chapel Hill Methods of hydrating mucosal surfaces
US6926911B1 (en) * 1998-12-22 2005-08-09 The University Of North Carolina At Chapel Hill Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
JP2004513870A (ja) * 1999-07-19 2004-05-13 ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル ナトリウムチャネルブロッカーの結合物及びその使用法
WO2001055390A1 (en) * 2000-01-28 2001-08-02 Human Genome Sciences, Inc. Human serpin polynucleotides, polypeptides, and antibodies
US6858614B2 (en) * 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenolic guanidine sodium channel blockers
US6858615B2 (en) * 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
US6903105B2 (en) * 2003-02-19 2005-06-07 Parion Sciences, Inc. Sodium channel blockers
US20050090505A1 (en) * 2003-08-18 2005-04-28 Johnson Michael R. Methods of reducing risk of infection from pathogens
AU2004264441A1 (en) * 2003-08-18 2005-02-24 Parion Sciences, Inc. Cyclic pyrazinoylguanidine sodium channel blockers
PT1663235E (pt) * 2003-08-18 2013-10-29 Parion Sciences Inc Novos bloqueadores dos canais do sódio de pirazinoílguanidina protegida
AU2004271945A1 (en) * 2003-08-18 2005-03-24 Parion Sciences, Inc. Aliphatic pyrazinoylguanidine sodium channel blockers
US7745442B2 (en) * 2003-08-20 2010-06-29 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens
US7399766B2 (en) * 2004-08-18 2008-07-15 Parion Sciences, Inc. Soluble amide & ester pyrazinoylguanidine sodium channel blockers
US7807834B2 (en) * 2005-08-03 2010-10-05 Parion Sciences, Inc. Capped pyrazinoylguanidine sodium channel blockers
JP2010502739A (ja) * 2006-09-07 2010-01-28 パリオン・サイエンシィズ・インコーポレーテッド ナトリウムチャネル阻害剤及び浸透圧調節物質を用いた処置による粘膜水和及び粘液クリアランスの改善

Similar Documents

Publication Publication Date Title
JP2010502738A5 (enExample)
KR102109223B1 (ko) 안구 건조 및 다른 점막 질환의 치료를 위한 나트륨 채널 차단제 활성을 보유하는 덴드리머 유사 아미노 아미드
JP2020019812A5 (enExample)
JP2010502739A5 (enExample)
JP6392242B2 (ja) 粘膜への水分付与が不十分であることが好都合である疾患の治療に有用なクロロ−ピラジンカルボキサミド誘導体
KR101654549B1 (ko) 다중방향족 나트륨 채널 차단제
JP4805824B2 (ja) キャップ化ピラジノイルグアニジンナトリウムチャネルブロッカー
KR20060037450A (ko) 사이클릭 피라지노일구아니딘 나트륨 채널 차단제
RU2018138195A (ru) Соединения 3,5-диамино-6-хлор-n-(n-(4- фенилбутил)карбамимидоил)пиразин-2-карбоксамида
JP2014530900A5 (enExample)
AR062741A1 (es) Metodo para aumentar la hidratacion de la mucosa y la evacuacion de l a mucosa mediante tratamiento con bloquadores de los canales del sodio y osmolitos
JP2010059210A (ja) ナトリウムチャネル遮断薬
US20070043012A1 (en) Methods to enhance chemotherapy
AR035611A1 (es) 2 -azetidinonas sustituidas con azucares, composicion farmaceutica, un kit, uso de dichos compuestos para la fabricacion de medicamentos utiles como agentes hipocolesterolemicos.
TW201920122A (zh) 3,5-二胺基-6-氯-n-(n-(4-(4-(2-(己基(2,3,4,5,6-五羥基己基)胺基)乙氧基)苯基)丁基)甲脒基)吡-2-甲醯胺
RU2014115290A (ru) Производные 1-фенил 2-пиридинилалкиловых спиртов в качестве ингибиторов
PT2637664T (pt) Composições e métodos de tratamento de hipertensão pulmonar
JP2015509075A5 (enExample)
JP2013526520A5 (enExample)
JP2018505163A5 (enExample)
KR102258465B1 (ko) 아릴알킬- 및 아릴옥시알킬-치환된 상피 나트륨 채널 차단 화합물
JP7610055B2 (ja) ジチオール糖粘液剤およびその使用
JP2018520986A5 (enExample)
JP2010501520A5 (enExample)
JP6255028B2 (ja) 肝細胞癌(hcc)の処置のための使用のための6−オキソ−1,6−ジヒドロ−ピリダジン誘導体